期刊文献+

脐带血清滴眼液治疗中重度干眼的临床研究 被引量:3

Umbilical cord serum eyedrops for dry eye
下载PDF
导出
摘要 目的观察脐带血清滴眼液治疗中重度干眼的临床疗效。方法收集22例(44眼)中重度干眼患者,予以脐带血清滴眼液治疗。治疗前及治疗后1周、1个月行干眼症状调查量表评分、泪膜破裂时间、泪液分泌试验、角膜荧光素染色检查并检测泪液中IL-6含量变化,治疗前及治疗后1个月行结膜印迹细胞学检查。结果治疗前及治疗后1周、1个月患者干眼症状调查量表评分、泪膜破裂时间、泪液分泌试验、角膜荧光素染色评分、泪氉液中IL-6含量分别为[(28.09±5.15)、(26.95±5.06)、(15.95±3.11)]、[(3.45±1.63)s、(3.82±1.76)s、(7.05±1.99)s]、[(3.31±1.08)mm、(3.44±1.06)mm、(3.61±1.15)mm)]、[(5.86±3.18)、(5.27±3.71)、(2.27±0.94)]、[(35.25±9.65)ng·L-1、(34.68±9.88)ng·L-1、(20.15±6.66)ng·L-1)]。治疗后1周各项检查指标与治疗前相比差异无统计学意义(均为P>0.05),治疗后1个月症状调查量表评分、泪膜破裂时间、角膜荧光素染色评分与治疗前相比均有明显改善,差异有统计学意义(均为P<0.001),泪液中IL-6含量下降差异有统计学意义(P<0.001),但泪液分泌量增加差异无统计学意义(P=0.054)。治疗后1个月结膜上皮细胞Nelson分级降低,杯状细胞密度由(89.77±15.85)mm-2增加到(161.36±24.79)mm-2,差异有统计学意义(P<0.001)。结论脐带血清滴眼液对于中重度干眼患者具有良好的治疗效果,能有效改善干眼患者的临床症状、体征和眼表炎症。 Objective To evaluate the therapeutic effect of umbilical cord serum eyedrops for moderate and severe dry eye. Methods Twenty-two patients (44 eyes) with moderate or severe dry eye were recruited and treated with umbilical cord serum eyedrops. Symptom questionnairs were self-answered and multiple dry eye-related clini- cal tests (tear film break-up time, Schirmer I test, corneal fluorescein staining)were performed before treatment and 1 week, 1 month after treatment. IL-6 levels in tears were measured, and conjunctival impression cytology was performed. Results The questionnaire score,tear film break-up time, Schirmer I test, fluorescein staining score and concentration of IL-6 in tears before treatment and 1 week, 1 month after treatment were (28.09 ±5.15,26.95 ±5.06,15.95 ±3. 11), [ (3.45 ±1.63)s, (3.82 ±1.76)s and (7.05 ±1.99) s], (3.31 ±1.08) mm, (3.44 ±1.06) mm, (3.61 ±1.15) mm, (5.86 ±3.18, 5.27 ±3.71,2.27 ±0.94) ,[ (35.25 ±9.65)ng· L^-1, (34.68 ±9.88)ng· L^-1, (20. 15 ±6. 66)ng · L^-1 ] ,respectively,there was no statistical improvement in all parameters at 1 week after treatment ( all P〉0.05) ,and there was significant improvement in question- naire score, tear film break-up time, fluorescein staining score at 1 month after treat- ment(all P 〈 0. 001 ). The concentration of IL-6 in tears significantly decreased at 1 month after treatment(P 〈0. 001 ) ,but there was no statistical change in Schirmer I test at 1 month after treatment (P = 0. 054 ). In impression cytology, the grade of squamous metaplasia decreased and goblet cell density increased from ( 89.77 ±15.85 ) mm^-2 to (161.36 ±24.79)mm^-2(P〈0. 001). Conclusion Umbilical cord serum eyedrops is effective and safe for moderate and severe dry eye,and the symptom and sign of dry eye and the ocular surface imflanunation can be ameliorated.
出处 《眼科新进展》 CAS 北大核心 2014年第2期162-165,共4页 Recent Advances in Ophthalmology
基金 南京医科大学重点课题基金项目资助(编号:2010NJMUZ01)~~
关键词 干眼 脐带血清滴眼液 白细胞介素-6 结膜印迹细胞学 dry eye umbilical cord serum eyedrops interleukin-6 conjunctival impression cytology
  • 相关文献

参考文献11

  • 1Nelson JD. Impression cytology[J]. Cornea, 1988,17 ( 1 ) :71- 81.
  • 2Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study [ J ]. Ophthaimology, 2003, 110 ( 6 ) : 1096- 1101.
  • 3Abelson MB,Ousler GW 3rd,Maffei C. Dry eye in 2008[ J]. Curr Opin Ophthalmol, 2009,20 ( 4 ) : 282-286.
  • 4Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders [ J ]. Br J Ophthalmol, 2004, 88( 11 ) : 1467-1474.
  • 5Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized come-control study[J]. Am J Ophthalmol,2005,139(2) :242-246.
  • 6Huang WC, Chiang CC, Tsai YY. Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery[ J]. Cornea ,2008,27 ( 9 ) : 1097.
  • 7Lavaju P, Sharma M, Sharma A, Chettri S. Use of amniotic mem- brane and autologous serum eye drops in Mooren' s ulcer[J]. Nepal J Ophthalmol, 2013,5 ( 9 ) : 120-123.
  • 8Yoon KC, Im SK, Park YG, Jung YD, Yang SY, Choi J. Applica- tion of umbilical cord serum eye drops for the treatment of dry eye syndrome [J]. Cornea,2005,25 (4) : 258-272.
  • 9Yoon KC, Jeong IY, Im SK, Park YG, Kim H J, Choi J. Therapeu-tic effect of umbilical cord serum eye drops for the treatment of dry eye associated with graft-versus-host disease[ J]. Bone Mar- row Transplant,2007,39 ( 3 ) :231-235.
  • 10Yoon KC, Heo H, Ira SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome[ J]. Ant J Ophthalmol,2007,144( 1 ) :86-92.

二级参考文献15

  • 1Pflugfelder SC. Antiinflammatory therapy for dry eye[J].American Journal of Ophthalmology,2004,(2):337-342.doi:10.1016/j.ajo.2003.10.036.
  • 2Vitali C,Bombardieri S,Jonsson R. Classification criteria for Sj(o)gren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group[J].Annals of the Rheumatic Diseases,2002.554-558.
  • 3Sahai A,Malik P. Dry eye:prevalence and attributable risk factors in a hospital-based population[J].Indian Journal of Ophthalmology,2005.87-91.
  • 4Kassan SS,Moutsopoulos HM. Clinical manifestations and early diagnosis of Sj(o)gren syndrome[J].Archives of Internal Medicine,2004.1275-1284.
  • 5Stern ME,Gao J,Schwalb TA. Conjunctival T-cell subpopulationsin Sj(o)gren's and non-Sj(o)gren's patients with dry eye[J].Investigative Ophthalmology & Visual Science,2002.2609-2614.
  • 6Oshida T,Iwata M,Sakimoto T. Tumor necrosis factor-alpha in tears of patients with Sj(o)gren syndrome[J].Nihon Ganka Gakkai Zasshi,2004.297-301.
  • 7Turner K,Pflugfelder SC,Ji Z. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion[J].Cornea,2000.492-496.
  • 8Rolando M,Barabino S,Mingari C. Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes[J].Cornea,2005,(8):951-954.doi:10.1097/01.ico.0000157421.93522.00.
  • 9Solomon A,Dursun D,Liu Z. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease[J].Investigative Ophthalmology & Visual Science,2001.2283-2292.
  • 10Tishler M,Yaron I,Shirazi I. Increased salivary interleukin-6 levels in patients with primary Sj(o)gren's syndrome[J].Rheumatology International,1999.125-127.

共引文献9

同被引文献46

  • 1蒋鹏飞,彭俊,彭清华.密蒙花颗粒对去势诱导的干眼症兔泪腺细胞IL-12及IL-6的影响[J].北京中医药大学学报,2019,42(6):477-482. 被引量:29
  • 2Serruya LG,Noqueira DC,Hida RY. Schinner test performed withopen and closed eyes : variations in normal individuals [ J ] . ArqBras Oftalmol .2009,72( 1) :65-67.
  • 3Han SB,Hyon JY, Woo SJ,Lee JJ,Kim TH,Kim KW. Prevalenceof Diy eye disease in an elderly Korean population [ J ]. ArchOphialmol,2011,129(5) :633-638.
  • 4Nichols KK,Mitchell GL,Zadnik K. The repeatability of clinicalmeasurements of diy eye[ J]. Cornea,2004,23(3) :272-285.
  • 5Nichols KK,Nichols JJ,Mitchell LG. The lack of association be-tweensigns and symptoms in patients with dry eye disease[ J].Cornea,2004,23(8) :762-770.
  • 6Li N,Deng XG,He MF. Comparison of the Schirmer I test withan without topical anesthesia for diagnosing dry eye[ J]. Int JOphthalmol ,20X2,5 (4) :478481.
  • 7Shafi T, Koay P. Randomised prospective masked study compa-ring patient comfort following the instillation of topical proxy-metacaine and amethocaine [ J ]. Br J Ophthalmol, 1998,82(11):1285-1287.
  • 8Lawrenson JG,Edgar DF,Tanna GK,Gudgeon AC. Comparisonof the tolerability and efficacy of unit-dose, preservative-freetopical ocular anaesthetics[ J]. Ophthalmic Physiol Opt, 1998,18(5) :393400.
  • 9Hung CH,Wang JJ,Chen YC,Chu CC,Chen YW. Intrathecaloxybuprocaine and proxymetacaine produced potent and long-lasting spinal anesthesia in rats [ J]. Neurosci Lett’ 2009,454(3):249-253.
  • 10Davis MJ, Pollack JS, Shott S. Comparison of topical anestheticsfor intravitreal injections: a randomized clinical trial [ J]. Reti-na,2012,32(4) :701-705.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部